# Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-and-antitumor-activity-of-the-anti-pd-1-antibody-pembrolizumab-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Bert H. O’Neil,John M. Wallmark,David Lorente,Elena Élez,Judith Raimbourg,Carlos Gomez‐Roca,Samuel Ejadi,Sarina A. Piha‐Paul,Mark N. Stein,Albiruni R. Abdul Razak,Katia Dotti,Armando Santoro,Roger B. Cohen,M. Gould,Sanatan Saraf,Karen Stein,Sae‐Won Han |
| Citations | 306 |
| DOI | 10.1371/journal.pone.0189848 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0189848&type=printable |
| OpenAlex ID | https://openalex.org/W2776526327 |
| PMID | 29284010 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Judith Raimbourg](https://scholariq.org/researchers/judith-raimbourg/)

## Paper journal

- [PLoS ONE](https://scholariq.org/journals/plos-one/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Colorectal and Anal Carcinomas](https://scholariq.org/topics/colorectal-and-anal-carcinomas/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.